Review article

DYSLIPIDEMIA AND STROKE IN PATIENTS WITH CHRONIC KIDNEY DISEASE

PETAR KES ; University of Zagreb, School of Medicine, Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Zagreb University Hospital Center, Department of Internal Medicine, Zagreb, Croatia
VANJA BAŠIĆ-KES ; University of Zagreb, School of Dental Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
VESNA FURIĆ-ČUNKO ; University of Zagreb, School of Medicine, Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Zagreb University Hospital Center, Department of Internal Medicine, Zagreb, Croatia
INES MESAR ; University of Zagreb, School of Medicine, Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Zagreb University Hospital Center, Department of Internal Medicine, Zagreb, Croatia
NIKOLINA BAŠIĆ-JUKIĆ ; University of Zagreb, School of Medicine, Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Zagreb University Hospital Center, Department of Internal Medicine, Zagreb, Croatia

Abstract

Altered lipid and lipoprotein metabolism occurs in patients with chronic kidney disease (CKD). Dyslipidemia persists in patients on chronic hemodialysis or peritoneal dialysis and even in renal transplant recipients, and contributes to accelerated atherosclerosis but may also contribute to the progression of kidney disease as well. The etiologies of altered lipid profile in patients with CKD, dialysis, and renal transplant recipients are complex because there are profound changes in the structure and function of lipoprotein and lipid molecules, which lead to accelerated atherosclerosis, cardiovascular disease and stroke. Cardiovascular disease and stroke are the major cause of morbidity and mortality in patients with impaired renal function. In this review, the pathogenesis and treatment of CKD-induced dyslipidemia are discussed. Studies on lipid abnormalities in predialysis, hemodialysis and peritoneal dialysis patients are analyzed. In addition, results of the studies that tested the effects of hypolipidemic drugs on stroke morbidity and mortality in patients with CKD are reported.

Keywords

dyslipidemia; chronic kidney disease; stroke; hemodialysis; peritoneal dialysis; renal transplantation

Hrčak ID:

126806

URI

https://hrcak.srce.hr/126806

Publication date:

14.9.2014.

Article data in other languages: croatian

Visits: 3.385 *